JOURNAL OF CLINICAL SURGERY ›› 2023, Vol. 31 ›› Issue (2): 164-167.doi: 10.3969/j.issn.1005-6483.2023.02.020

Previous Articles     Next Articles

Differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma based on Mueller Matrix Polarimetry and machine learning

  

  1. Department of Pathology,Clinical Oncology School of Fujian Medical University,Fujian Cancer Hospital,Fujian,Fuzhou 350014,China
  • Received:2022-03-19 Revised:2022-03-19 Accepted:2022-03-19 Online:2023-02-20 Published:2023-02-20

Abstract: Objective To investigate the role of total polarization imaging and machine learning in the differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma.Methods Polarization imaging was performed on 8 cases of poorly differentiated hepatocellular carcinoma and 8 cases of poorly differentiated cholangiocarcinoma.Pathologists selected three Regions of interest(ROIs) according to HE slices,measured the mueller matrix polarimetry of each ROI,and calculated a series of polarization basic parameters according to the mueller matrix  extraction analysis method.The polarization basic parameters were input into the artificial neural Network(ANN) model,and the 8-fold cross-validation method was used to train and verify the model in three categories.Results ANN model showed that the The precision and sensitive of differentiating hepatocellular carcinoma cells,Cholangiocarcinoma cells and other tissues based on mueller matrix polarimetry was 0.846-3 and 0.810-7.Conclusion The diagnostic model of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on polarized imaging and machine learning is of great value in pathological auxiliary diagnosis,which can provide help for clinical accurate diagnosis and treatment.

Key words: hepatocellular carcinoma, intrahepatic cholangiocarcinoma, mueller matrix polarimetry, artificial neural network

[1] YANG Gang, WANG Guan, XIONG Yongfu, et al. Study on the expression of TP53 regulation of apoptosis inhibitor 1 in hepatoma cells and its effect on proliferation and apoptosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 471-474.
[2] LIN Meilong, WANG Wenqiang, LI Jian, et al. The diagnostic value of folate receptor-positive circulating tumor cells detection in patients with hepatocellular carcinoma with vascular invasion [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 364-367.
[3] ZHANG Yuping, SONG Lei, LI Chunyan, et al. LINC00221 promotes proliferation,migration and invasion in hepatocellular carcinoma through ERK signaling pathway [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(11): 1037-1040.
[4] YANG Jun, SUN Long, ZHAO Jianquan, et al. Relationship of plant homeodomain finger protein 2 expression with clinicopathological features and prognosis in hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(11): 1041-1043.
[5] . Clinical application of autologous tumor infiltrating lymphocytes combined with antiPD1 antibody in the treatment of advanced hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(8): 743-747.
[6] . Effect on liver hyperplasia and hepatocellular carcinoma growth after liver arterial ligation combined with partial portal ligation [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(4): 367-371.
[7] LI Jiang, HUANG Zhiyong.. Advances in immune microenvironment and immunotherapy of hepatocellular carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1089-1091.
[8] ZHANG Weiyi, XIA Wei, YUAN Guangchao, et al.. Sevoflurane inhibits the proliferation,invasion and migration of hepatocellular carcinoma cells through BACE1-AS and glycolysis [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 985-989.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] XIA Yujia, ZUO Weiwei, WANG Mengyuan, et al.. Application value of methylene blue in detection of lymph node in gastrointestinal malignant tumors:a Meta-analysis[J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(1): 59 -62 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(1): 4 -6 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 101 -102 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 102 -105 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 106 -108 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 109 -112 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 113 -117 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 117 -121 .
[9] DING Dashuai, LIAO Min, WANG Feng, et al. Relationship between renal pelvic drainage fluid protein level and renal function in adults with severe hydronephrosis nephrostomy[J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 122 -126 .
[10] GUAN Fuyong, WANG Li, WANG Junlin, et al. Risk factors of recurrence in patients with residual tumor after transurethral resection of bladder tumor for non muscular invasive bladder cancer[J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(2): 127 -131 .